These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19151662)

  • 1. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.
    Jarboe EA; Pizer ES; Miron A; Monte N; Mutter GL; Crum CP
    Mod Pathol; 2009 Mar; 22(3):345-50. PubMed ID: 19151662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.
    Zhang X; Liang SX; Jia L; Chen N; Fadare O; Schwartz PE; Kong B; Zheng W
    Am J Pathol; 2009 Jun; 174(6):2000-6. PubMed ID: 19435786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
    Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
    Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.
    Jarboe EA; Miron A; Carlson JW; Hirsch MS; Kindelberger D; Mutter GL; Crum CP; Nucci MR
    Int J Gynecol Pathol; 2009 Jul; 28(4):308-15. PubMed ID: 19483636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
    Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
    J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
    Trahan S; Têtu B; Raymond PE
    Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.
    Jia L; Yuan Z; Wang Y; Cragun JM; Kong B; Zheng W
    Mod Pathol; 2015 Jan; 28(1):118-27. PubMed ID: 24925054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
    Folkins AK; Jarboe EA; Saleemuddin A; Lee Y; Callahan MJ; Drapkin R; Garber JE; Muto MG; Tworoger S; Crum CP
    Gynecol Oncol; 2008 May; 109(2):168-73. PubMed ID: 18342932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
    Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
    Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
    Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
    Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fallopian tube abnormalities in uterine serous carcinoma.
    Steenbeek MP; Bulten J; Snijders MPLM; Lombaers M; Hendriks J; van den Brand M; Kraayenbrink AA; Massuger LFAG; Sweegers S; de Hullu JA; Pijnenborg JMA; Küsters-Vandevelde HVN; Reijnen C
    Gynecol Oncol; 2020 Aug; 158(2):339-346. PubMed ID: 32409160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.
    Shaw PA; Rouzbahman M; Pizer ES; Pintilie M; Begley H
    Mod Pathol; 2009 Sep; 22(9):1133-8. PubMed ID: 19543244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.
    Chen EY; Mehra K; Mehrad M; Ning G; Miron A; Mutter GL; Monte N; Quade BJ; McKeon FD; Yassin Y; Xian W; Crum CP
    J Pathol; 2010 Sep; 222(1):110-6. PubMed ID: 20597068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metachronous serous endometrial intraepithelial carcinoma and serous peritoneal carcinoma: analysis of probable independent lesions.
    Furuya M; Sato T; Tanaka R; Yamamoto M; Yokota NR; Miyagi E
    Diagn Pathol; 2016 Nov; 11(1):130. PubMed ID: 27842566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serous carcinogenesis in the fallopian tube: a descriptive classification.
    Jarboe E; Folkins A; Nucci MR; Kindelberger D; Drapkin R; Miron A; Lee Y; Crum CP
    Int J Gynecol Pathol; 2008 Jan; 27(1):1-9. PubMed ID: 18156967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
    McCluggage WG; Sumathi VP; McManus DT
    Hum Pathol; 2003 Sep; 34(9):939-43. PubMed ID: 14562291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.